Can a pinpoint pollen dose unmask allergy triggers?

NCT ID NCT05346718

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This study aims to find the lowest concentrations of ragweed and birch pollen that cause allergy symptoms in people with seasonal allergic rhinitis. Participants sit in a special chamber where pollen levels are carefully controlled, and their nasal symptoms are measured. The goal is to understand how potent ragweed pollen is compared to birch pollen.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ragweed pollen, birch pollen, and clean air (placebo) exposure in an allergen challenge chamber
What this could lead to
If successful, this could help set evidence-based pollen warning thresholds and improve allergy management for ragweed and birch.
What could go wrong
This is a small, early-phase study with only 18 participants, so results may not apply broadly. Allergic reactions during exposure are a risk.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC RHINITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fraunhofer Institute for Toxicology and Experimental Medicine

    Hanover, Lower Saxony, 30625, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.